{"entity":{"id":"bionemo","kind":"technology","name":"NVIDIA BioNeMo","aka":[],"tldr":"NVIDIA BioNeMo is a software stack, not a model: GPU-optimised training recipes and inference services on which protein, DNA and single-cell foundation models such as Evo 2, ESM and Geneformer are trained and served. The Arc Institute, Recursion and pharmaceutical companies use it, at the price of being tied to NVIDIA hardware and tooling.","summary":"NVIDIA BioNeMo is a software stack rather than a single model: frameworks, training recipes and inference microservices optimised for GPUs that biology foundation models are trained and served with. It supports protein, DNA and single-cell models, including Evo 2, ESM and Geneformer, and is used by the Arc Institute, Recursion and pharmaceutical companies to train large models efficiently. Its role in oncology is indirect, as the infrastructure beneath the structure, genome and cell models that feed drug discovery. Because it is vendor-specific, it ties users to NVIDIA hardware and tooling, a practical trade-off against portability. For a newcomer: BioNeMo is the plumbing that many biology AI models run on, not a model that makes predictions itself.","status":"established","asOf":"2026-09-08","links":[{"label":"NVIDIA BioNeMo","url":"https://www.nvidia.com/en-us/clara/bionemo/"}],"tags":["infrastructure"],"related":["evo2"],"cancers":[],"sections":["ai-computation","drug-discovery"],"technologies":[],"targets":[],"drugs":[],"companies":["nvidia"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"BioNeMo provides optimised training and inference libraries on GPUs.","strengths":["Infrastructure standard"],"limitations":["Vendor-specific"],"since":2023},"route":"/technologies/bionemo/","neighbours":{"technology":[{"id":"evo2","kind":"technology","name":"Evo 2 (Arc Institute, NVIDIA)","route":"/technologies/evo2/"}],"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"company":[{"id":"nvidia","kind":"company","name":"NVIDIA","route":"/companies/nvidia/"}],"roadmap":[{"id":"ai-oncology-roadmap","kind":"roadmap","name":"AI in oncology roadmap: pattern readers → foundation models → agents in the workflow","route":"/roadmaps/ai-oncology-roadmap/"}]}}